A Phase 1 Clinical Study of NXP800 in Subjects with Advanced Cancers and Expansion in Subjects with Ovarian Cancer

The University of Virginia is participating in a clinical research study for adults ages 18 and over, who have ovarian clear cell or ovarian endometrioid cancer, and have an ARID1a mutation.

Study-related procedures that are being done beyond your standard of care will be provided at no cost to you or your insurance.

Additional information can be found here: https://clinicaltrials.gov/ct2/show/NCT05226507